Summit Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 02/17/2026 | 36.39 M | $636.48 M | 7.91% | 4.90% |
| FMR LLC | 02/17/2026 | 13.36 M | $233.68 M | 49.82% | 1.80% |
| VANGUARD GROUP INC | 01/29/2026 | 11.18 M | $195.49 M | -1.78% | 1.50% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 9.37 M | $163.91 M | 106.47% | 1.26% |
| BLACKROCK, INC. | 02/12/2026 | 9.36 M | $163.74 M | 27.13% | 1.26% |
| STATE STREET CORP | 02/13/2026 | 6.64 M | $116.07 M | 4.31% | 0.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.15 M | $55.06 M | 0.47% | 0.42% |
| CITADEL ADVISORS LLC | 02/17/2026 | 2.48 M | $43.30 M | 1,121.29% | 0.33% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 1.80 M | $31.53 M | 29.53% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 1.46 M | $25.59 M | 20.09% | 0.20% |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | 02/13/2026 | 1.42 M | $24.86 M | 73.89% | 0.19% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.38 M | $24.38 M | -13.74% | 0.19% |
| NORGES BANK | 02/10/2026 | 1.37 M | $24.03 M | 100.00% | 0.18% |
| APEIRON CAPITAL LTD | 02/02/2026 | 1.31 M | $22.90 M | -0.13% | 0.18% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 1.21 M | $21.08 M | 124.22% | 0.16% |
| ABRDN PLC | 01/16/2026 | 927.17 K | $16.22 M | -18.64% | 0.12% |
| MORGAN STANLEY | 02/13/2026 | 926.58 K | $16.21 M | -51.91% | 0.12% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 892.63 K | $15.61 M | 1.85% | 0.12% |
| UBS GROUP AG | 01/29/2026 | 870.72 K | $15.23 M | -31.91% | 0.12% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 715.41 K | $12.51 M | 551.40% | 0.10% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 710.00 K | $12.42 M | 0.00% | 0.10% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 578.25 K | $10.11 M | 2,210.22% | 0.08% |
| NOMURA HOLDINGS INC | 02/17/2026 | 542.23 K | $9.48 M | -48.31% | 0.07% |
| CANDRIAM S.C.A. | 04/30/2026 | 540.66 K | $9.46 M | 5.24% | 0.07% |
| NORTHERN TRUST CORP | 02/17/2026 | 528.49 K | $9.24 M | -3.25% | 0.07% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 485.57 K | $8.49 M | -2.41% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 477.39 K | $8.35 M | -27.37% | 0.06% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 469.02 K | $8.20 M | 289.18% | 0.06% |
| INVESCO LTD. | 02/19/2026 | 461.30 K | $8.07 M | 8.27% | 0.06% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 440.95 K | $7.71 M | 47.21% | 0.06% |
| LMR PARTNERS LLP | 02/17/2026 | 424.40 K | $7.42 M | 3.74% | 0.06% |
| TUDOR INVESTMENT CORP ET AL | 02/17/2026 | 423.08 K | $7.40 M | 21.84% | 0.06% |
| CITADEL ADVISORS LLC | 02/17/2026 | 417.50 K | $7.30 M | -42.52% | 0.06% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 415.28 K | $7.26 M | 217.92% | 0.06% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 376.56 K | $6.59 M | 0.53% | 0.05% |
| QVT FINANCIAL LP | 02/13/2026 | 360.52 K | $6.31 M | 0.00% | 0.05% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 357.87 K | $6.19 M | 90.88% | 0.05% |
| SCULPTOR CAPITAL LP | 02/13/2026 | 356.90 K | $6.24 M | 7.02% | 0.05% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 353.76 K | $6.19 M | -3.64% | 0.05% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 350.00 K | $6.12 M | 0.00% | 0.05% |
| BARCLAYS PLC | 02/13/2026 | 338.39 K | $5.92 M | -28.88% | 0.05% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 02/12/2026 | 338.36 K | $5.91 M | 0.00% | 0.05% |
| CITADEL ADVISORS LLC | 02/17/2026 | 318.80 K | $5.58 M | -46.66% | 0.04% |
| READYSTATE ASSET MANAGEMENT LP | 02/17/2026 | 306.18 K | $5.36 M | 100.00% | 0.04% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/13/2026 | 287.81 K | $5.03 M | -15.14% | 0.04% |
| JANE STREET GROUP, LLC | 02/12/2026 | 280.00 K | $4.90 M | -31.66% | 0.04% |
| JANE STREET GROUP, LLC | 02/12/2026 | 274.30 K | $4.80 M | -26.76% | 0.04% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 251.39 K | $4.40 M | 3.62% | 0.03% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 240.00 K | $4.20 M | 16.79% | 0.03% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 237.79 K | $4.16 M | -11.89% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Summit Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 279 institutional investors and hedge funds held shares of Summit Therapeutics Inc. The most heavily invested institutionals were:
UBS Group AG: 3.68 M
Pictet Asset Management Holding SA: 1.32 M
APEIRON CAPITAL Ltd: 1.31 M
abrdn plc: 665,364
Candriam S.C.A.: 540,662
Bank of New York Mellon Corp: 404,679
15.84% of Summit Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 135.39 M shares in the last 24 months. This purchase volume represents approximately $2.13 B in transactions.